Hipolin Faces Severe Financial Struggles Amidst Market Underperformance and Volatility
Hipolin, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a 39.32% decline over the past year. The company faces substantial financial challenges, including operating losses and a negative profit after tax, alongside a high percentage of pledged promoter shares.
Hipolin, a microcap player in the FMCG sector, has experienced significant volatility, hitting a new 52-week low of Rs. 70 today. This decline reflects a broader trend, as the stock has underperformed the market over the past year, with a staggering loss of 39.32%, contrasting sharply with the Sensex's gain of 5.97%. Today's trading activity was in line with sector performance, although Hipolin has shown erratic trading patterns, missing trades on one out of the last 20 days. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.
Financially, Hipolin is grappling with significant challenges, including operating losses and a weak long-term growth outlook. The company's operating profit has plummeted at an alarming annual rate of -183.09% over the past five years. Additionally, its ability to service debt is concerning, with an average EBIT to interest ratio of -1.98.
The recent financial results further underscore these issues, with a negative profit after tax of Rs. -2.36 crore, marking a dramatic decline of 790.6% compared to the previous quarter's average. With 39.76% of promoter shares pledged, the stock faces additional pressure in a declining market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
